Table 1A.

Clinical and laboratory findings for group A.

CaseAge, yrsSexANCA (EU)DiagnosisCRP, mg/dlCr, mg/dlHematuria, gradeProteinuria g/dayCrescents (%)Global Sclerosis (%)VasculitisOrgan Involvement (extrarenal)Initial TherapyMaintenance TherapyDisease Duration (mos)RelapseEnd of Followup
171FMPO 889MPA5.32.651.03280InterlobularILDPSL CYCPSL351Cr 1.0
284FMPO 297MPA2.78.741.62670Interlobular(–)PSL CYC20Death (renal failure)
360FMPO 640MPA8.791.1250.04211Arteriole Interlobular(–)mPSL pulse PSL, CYCPSL392Cr 1.7
480MMPO 78MPA12.13.320.885620Arteriole InterlobularILDmPSL pulse PSLPSL250Cr 2.9
558FMPO 288MPA13.4130.73588Interlobular ArcuateILDmPSL pulse PSLPSL200Cr 1.1
670FMPO 88MPA22.19.150.89794Pulmonary hemorrhagemPSL pulsePSL190Cr 2.1
InterlobularPSL
Intestinal hemorrhagePE
768FP (+)GPA11.91.140.5040Arteriole InterlobularILDPSLPSL1630Death (Intestinal perforation)
857FPR3 10GPA19.56.751.957010InterlobularPulmonary tumor NeuritismPSL pulse PSL, CYCPSL503Hemodialysis
966MMPO 359GPA5.70.640.13912InterlobularILD NeuritismPSL pulse PSL, CYCPSL MZB601Cr 1.8
1062MPR3 130GPA14.32451.66245ArteriolePulmonary tumormPSL pulsePSL60Cr 2.6
InterlobularCelebral infarctionPSL, CYC
ArcuateNeuritis Intestinal hemorrhage
  • Crescents: the percentage of glomeruli with crescents. ILD: interstitial lung disease; PSL: prednisonone; mPLSpulse: intravenous methylprednisolone pulse therapy; CYC: cyclophosphamide; MZB: mizorbine; GPA: granulomatosis with polyangiitis; EU: ELISA unit; CRP: C-reactive protein; Cr: creatinine; MPO: myeloperoxidase; MPA: microscopic polyangiitis; PR3: proteinase 3.